Genezen
genezen.com
Actively hiring
Cell & Gene Therapy
CRO & CDMO Services
As featured in
View 19 jobs
Claim pageClaim
Follow
Overview
Connections
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
Funding and backers
Hiring now
21
+6 posted in 30 days
Backers
1
Ampersand Capital Partners
Momentum
26/100
hiring for its size, in the news
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 3
Partnership Genezen and the Raiden Science Foundation Announce Partnership for AAV9 Gene Replacement Therapy for UBA5 Clinical Trial · genezen.com
May 12
Partnership Genezen Expands Partnership with SGS to Strengthen Support for Foundation-Funded Gene Therapy Programs · genezen.com
Nov 7, 2025
Partnership Genezen Partners with Charlotte & Gwenyth Gray Foundation on CLN6 Batten Disease · genezen.com
Nov 3, 2025
Recognition Genezen Named a BioSpace 2026 Best Places to Work Winner · genezen.com
May 4, 2025
Partnership Genezen and Optieum Biotechnologies Partner to Support cGMP Manufacturing of Groundbreaking CAR-T Therapy for Glioblastoma · genezen.com
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
backs Forge Biologics
backs Somagenetix
Similar startupsby what they do, their industry and backers
Borea therapeuticsBorea Therapeutics: Next-generation viral vectors for targeted gene therapy.
Cirsium Biosciences is democratizing gene therapy through transformative viral vector production methods and systems.
Forge Biologics is accelerating gene therapy manufacturing: high-yield AAV manufacturing, a world-class cGMP facility, and seamless support.
Leading contract research organization for preclinical CRO services and clinical trials. Advancing drug discovery with expert research…
ProtaGene is a world-leading CRO partner for the biopharmaceutical and gene and cell therapy industries.
At Viralgen, we're proud to be known for just one thing: Being a world leader in AAV-based gene therapy manufacturing.. We're all in on…
How Genezen hires
Truth index
B 83/100
Median time to fill
46 days
Ghost roles
0%
Stale roles
67%
Reposted roles
0%
Genezen scores B on the Alion truth index (A is best, E worst), measured over 3 open roles re-checked against its own hiring board: 0% look like ghost listings, 67% have gone stale and 0% are the same role posted again. Its roles close in a median of 46 days. It measures how much of what this employer publishes turns into a real, finite search - not the employer as a workplace. How the index is computed
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Ampersand Capital PartnersVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
4basebio and Genezen Enter into Strategic Collaboration to Advance Synthetic, Cell-Free DNA Platforms for Next-Generation Viral Vector Manufacturing
Commercial collaboration combines 4basebio's synthetic DNA technology with Genezen's viral vector development and manufacturing expertise to support gene therapy programs from early development through clinical and commercial manufacturing. CAMBRIDGE, UK
Read more
Report
4basebio and Genezen Enter into Strategic Collaboration to Advance Synthetic, Cell-Free DNA Platforms for Next-Generation Viral Vector Manufacturing - Company Announcement - FT.com
The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and dealings.
Read more
Report
Genezen and the Raiden Science Foundation Announce Partnership for AAV9 Gene Replacement Therapy for UBA5 Clinical Trial
Indianapolis, IN and Beaverton, OR - August 3, 2026 - Genezen, a best-in-class gene therapy contract development and manufacturing organization (CDMO), and the Raiden Science Foundation (RSF), a parent-led rare disease organization, today announced a manu
Read more
Report
Genezen Expands Partnership with SGS to Strengthen Support for Foundation-Funded Gene Therapy Programs
Expanded collaboration helps remove barriers and enables more programs to advance toward the clinic by improving and accelerating access to critical analytical and GMP biosafety testing. Genezen, a best-in-class viral vector contract development and manuf
Read more
Report
Genezen and The Charlotte & Gwenyth Gray Foundation to Cure Batten Disease Announce Manufacturing Partnership for CLN6 Gene Therapy Clinical Trial
Indianapolis, IN and Los Angeles, CA - April 28, 2026 - Genezen, a gene therapy contract development and manufacturing organization (CDMO), and The Charlotte & Gwenyth Gray Foundation to Cure Batten Disease today announced a manufacturing partnership to a
Read more
Report
Genezen and Atsena Therapeutics Announce Strategic Commercial Manufacturing Partnership
Lexington, MA and Durham, NC - January 20, 2026 - Genezen, a leading gene therapy contract development and manufacturing organization (CDMO), and Atsena Therapeutics ("Atsena"), a clinical-stage gene therapy company focused on using the life-changing powe
Read more
Report
Genezen Announces Manufacturing Partnership with Humane Genomics to Advance Oncolytic Virus Therapy for Pediatric Liver Cancer
Indianapolis, IN and New York, NY, - November 12, 2025 - Genezen, a leading viral vector Contract Development and Manufacturing Organization (CDMO), and Humane Genomics, a biotechnology company developing oncolytic viral therapies, today announced a partn
Read more
Report
Genezen Partners with Charlotte & Gwenyth Gray Foundation on CLN6 Batten Disease
Imagine a disease that robs you of your sight, your movement, and cognitively impairs you before it becomes fatal? Now imagine this happening to a child. This is often the reality of Batten's disease. The team at Genezen is honored to partner with the Cha
Read more
Report
Genezen Named a BioSpace 2026 Best Places to Work Winner
We are thrilled to announce that we have been named a BioSpace 2026 Best Place to Work. As a best-in-class gene therapy CDMO, we pride ourselves on our flexibility and scalability of our sites to work with innovators at every stage to deliver life-saving
Read more
Report
Genezen and Elly's Team Advance AAV9 Gene Therapy for NEDAMSS
Lexington, MA and New York, NY, May 11, 2025 - Genezen, a leading gene therapy CDMO, has partnered with Elly's Team, a foundation dedicated to accelerating the translation of medical research into treatments, for an AAV9 gene replacement therapy targeting
Read more
Report
Show more news
Tech stack
Technologies named in job postings at Genezen over the last 12 months, by layer, with the share of postings for each.
Technologies in use
21
Postings analysed
27
Stack modernity
58/100
Languages
PowerShell4%
Cloud & platforms
Linux4%
AWS4%
Azure4%
VMWare4%
Sign in to see how your skills match this stack
Sign In
Full Genezen tech stack
21 technologies · by team · pay by technology · changes · similar stacks
Salary insights
Compensation ranges based on this company's open jobs
Median
$130k
Typical range
$66k – $240k
Open positions
11
11
Jobs
Junior
18.2%
Middle
36.4%
Senior
45.5%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Junior | 2 | $88k | $66k – $110k |
| Middle | 4 | $93k | $86k – $130k |
| Senior | 5 | $165k | $140k – $240k |
Highest paying role
Director/Sr. Director, Quality Assurance Operations
$240k
Normalized to USD per year
All salaries at Genezen
By role, level and city, against the market · 11 jobs with pay
Growth
Hiring Momentum
50/100
Stable
Open positions
21
5 opened / 7 closed in 30 days
Median time-to-fill
59 days
faster than 23% of the market
ATS activity
Every ~4 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Industrial Engineering
48% ▲
QA
12% ▼
Field & Service
12%
Analytics
8% ▼
Management
4% ▼
Sales
4% ▼
Actively hiring for Industrial Engineering (+5 in 30 days)
Activity Timeline
Added FMEA to stack
Oct 2026
Added CAPA to stack
Oct 2026
New location: Lexington
Oct 2026
Added Microsoft Office to stack
Sep 2026
Added Linux to stack
Sep 2026
Added AutoCAD to stack
Sep 2026
Offices
Where the company hires and what each office is for
Cities
4
Hiring now
3
Countries
1
Busiest office
Lexington
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Lexington
United States
HQ
Massachusetts
14 open roles 13 posted in 90 days 14% engineering $129k Avg Salary
hires for Industrial Engineering, Field & Service, DevOps
Lexington
United States
Plant / site
Massachusetts
15 open roles 16 posted in 90 days 13% engineering $129k Avg Salary
hires for Industrial Engineering, Field & Service, DevOps
Indianapolis
United States
Plant / site
Genezen Locations
7 open roles 8 posted in 90 days 14% engineering
hires for Industrial Engineering, Field & Service, Management
9900 Westpoint Dr, Suite 128, Indianapolis, IN 46256
Fishers
United States
Regional office
Fishers Office
Jobs
$130k – $165k per year · In office · 7+ years exp · Lexington · Lexington
GMP
MedTech
CAPA
Apply
$150k – $170k per year · In office · 3+ years exp · Bachelor's Degree · Lexington · Lexington
FMEA
Life Sciences
GMP
MedTech
CAPA
Apply
$170k – $240k per year · In office · 10+ years exp · Bachelor's Degree · Lexington · Lexington
Microsoft Excel
Life Sciences
GMP
MedTech
CAPA
Apply
≈ $66k – $120k per year (Estimated) · In office · 4+ years exp · Indianapolis
Cell Culture
Bioreactors
GMP
MedTech
CAPA
Apply
≈ $95k – $179k per year (Estimated) · In office · 8+ years exp · Lexington
GMP
MedTech
CAPA
Apply
≈ $53k – $95k per year (Estimated) · In office · 1+ year exp · High School Diploma · Indianapolis
Microsoft Excel
Life Sciences
GMP
Apply
≈ $52k – $93k per year (Estimated) · In office · 3+ years exp · Bachelor's Degree · Lexington · Lexington
GMP
Apply
≈ $80k – $151k per year (Estimated) · In office · 5+ years exp · Bachelor's Degree · Indianapolis
AutoCAD
Life Sciences
GMP
MedTech
CAPA
Apply
$85k – $110k per year · In office · 2+ years exp · Bachelor's Degree · Lexington · Lexington
qPCR
ELISA
Mass Spectrometry
HPLC
GMP
LIMS
Apply
≈ $66k – $124k per year (Estimated) · In office · 3+ years exp · Bachelor's Degree · Indianapolis
Cell Culture
GMP
Apply
$115k – $140k per year · In office · 7+ years exp · Bachelor's Degree · Lexington · Lexington
GMP
MedTech
21 CFR Part 11
CAPA
Apply
$140k – $165k per year · In office · 7+ years exp · Bachelor's Degree · Lexington · Lexington
PowerShell
VMWare
Azure
AWS
Hyper-V
Linux
Life Sciences
GMP
Apply